lated upon DC maturation as induced by LPS (47, 56) . Moreover, Kv channels sustain Ca 2ϩ influx through Ca 2ϩ releaseactivated channels (CRAC) by maintaining the negative membrane potential and providing the necessary electrical driving force in DCs. Accordingly, Kv channel inhibitors impair Ca 2ϩ -dependent cytokine production, maturation, and migration of murine DCs (45) .
Kv channels in DCs are under tonic inhibition by phosphoinositide-3-kinase (PI3K) (56) . PI3K negatively regulates TLRmediated proinflammatory cytokine production in DCs and belongs to the gate-keeping system, preventing excessive proinflammatory immune responses (20, 21). PI3K-dependent inhibition of Kv channels may contribute to the PI3K-mediated DC suppression.
The present study has been performed to elucidate whether Kv channels in DCs are influenced by rapamycin. The findings were confirmed in the Xenopus oocyte expression system.
MATERIALS AND METHODS

Animals.
All animal experiments were conducted according to the German law for the welfare of animals and were approved by local authorities.
Culture of bone marrow dendritic cells. Dendritic cells were isolated from bone marrow of 7-to 12-wk-old male and female NMRI mice (Charles River, Sulzfeld, Germany). The cells were cultured for 7 days in RPMI 1640 (GIBCO, Carlsbad, CA) containing 10% FCS, 1% penicillin-streptomycin, 1% glutamine, 1% nonessential amino acids, and 0.05% ␤-mercaptoethanol. Cultures were supplemented with granulocyte-macrophage colony-stimulating factor (GM-CSF; 35 ng/ml, Preprotech Tebu) and fed with fresh medium containing GM-CSF on days 3 and 6. Experiments were performed at day [7] [8] [9] . At day 7, Ն80% of the cells expressed CD11c, a marker for mouse DCs, and were positive for CD86 and MHC II. Where pointed out, rapamycin was applied for the indicated periods and at the indicated concentrations.
Immunostaining and flow cytometry. Cells (4 ϫ 10 5 ) were incubated in 100 l PBS containing fluorochrome-conjugated antibodies at a concentration of 10 g/ml. A total of 1 ϫ 10 4 cells were analyzed. The following antibodies (all from BD Pharmingen, Heidelberg, Germany) were used for staining: FITC-conjugated anti-mouse CD11c, clone HL3 (Armenian hamster IgG 1, 2), PE-conjugated anti-mouse CD86, clone GL1 (Rat IgG 2a, ) and phycoerythrin (PE)-conjugated rat anti-mouse I-A/I-E (MHC II), clone M5/114.15.2 (IgG2b, ).
Patch clamp. Patch-clamp experiments were performed at room temperature in voltage-clamp, fast whole cell mode according to Hamill et al. (29) . The cells were continuously superfused through a flow system inserted into the dish. The bath was grounded via a bridge filled with NaCl Ringer solution. Borosilicate glass pipettes (1-3 M⍀ tip resistance; GC 150 TF-10, Clark Medical Instruments, Pangbourne, UK) manufactured by a microprocessor-driven DMZ puller (Zeitz, Augsburg, Germany) were used in combination with a MS314 electrical micromanipulator (MW, Märzhäuser, Wetzlar, Germany). The currents were recorded by an EPC-9 amplifier (Heka, Lambrecht, Germany) using Pulse software (Heka) and an ITC-16 Interface (Instrutech, Port Washington, NY). Whole cell currents were elicited by 200-ms square wave voltage pulses from Ϫ90 to ϩ90 mV in 20-mV steps delivered at 20-s intervals from a holding potential of Ϫ70 mV. Kv currents in DCs were shown to recover from their use-dependent inactivation within 20 s (55) . The currents were recorded with an acquisition frequency of 10 kHz and 3 kHz low-pass filtered.
The cells were superfused with a bath solution containing (in mmol/l) 140 NaCl, 5 KCl, 1 MgCl 2, 2 CaCl2, 10 glucose, and 10 HEPES, pH 7.4 (NaOH). The patch-clamp pipettes were filled with an internal solution containing (in mmol/l) 80 KCl, 60 K ϩ -gluconate, 1 MgCl2, 1 Mg-ATP, 1 EGTA, and 10 HEPES, pH 7.2 (KOH).
The offset potentials between both electrodes were zeroed before sealing. The potentials were corrected for liquid junction potentials as estimated according to Barry and Lynch (5) . The original whole cell current traces are depicted without filtering (acquisition frequency of 5 kHz), and currents of the individual voltage square pulses are superimposed. The applied voltages refer to the cytoplasmic face of the membrane with respect to the extracellular space. The inward currents, defined as flow of positive charge from the extracellular to the cytoplasmic membrane face, are negative currents and depicted as downward deflections of the original current traces.
In vitro expression and Xenopus oocyte electrophysiology. For generation of cRNA, constructs were used encoding Kv1.3 (31), Kv1.5 (6, 40) , and mTOR (36) . The cRNA was generated as described previously (32, 57) . For electrophysiology, Xenopus oocytes were prepared as previously described (62) . Fifteen nanograms of wild-type mTOR were injected on the first day and 1 ng Kv1.3 or Kv1.5 cRNA on the second day after preparation of the Xenopus oocytes and incubated at 17°C in ND96 solution plus sodium pyruvate, gentamycin, tetracycline, and theophylline. Experiments were performed at room temperature 4 -5 days after the second injection. For recordings, the oocytes were placed in a chamber continuously perfused with ND96 solution and recorded with two-electrode voltage-clamp technique (7) . To obtain current-voltage curves, oocytes were held at a holding potential of Ϫ100 mV and current was measured following voltage steps between Ϫ80 and ϩ60 mV. For activation and inactivation analysis, single exponential functions were fitted to the rising or decaying portions of the curves, respectively, and time constants of activation and inactivation were determined. The data were filtered at 1 kHz and recorded with a GeneClamp 500 amplifier, a DigiData 1300 A/D-D/A converter, and the pClamp 9.0 software package for data acquisition and analysis (Axon Instruments). The control solution (superfusate/ND96) contained 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2, 1 mM MgCl2, and 5 mM HEPES, pH 7.4. Final solutions were titrated to pH 7.4 using NaOH. The flow rate of the superfusion was 20 ml/min, and a complete exchange of the bath solution was reached within ϳ10 s. Where indicated, n represents the number of oocytes A: representative tracings illustrating whole cell Kv currents in bone marrow-derived DCs cultured under control conditions (control) and following overnight treatment of the cells with 100 nM rapamycin. The currents were recorded from the cells with similar capacitance elicited by 200-ms depolarizing pulses ranging from Ϫ90 to ϩ90 mV in 20-mV and 20-s increments from a holding potential of Ϫ80 mV. B: mean current-voltage (I-V) relationships (Ϯ SE, n ϭ 8 -9) of peak Kv current density in DCs without (□) and with () prior overnight treatment with 100 nM rapamycin. C: time dependence of rapamycin effect on Kv current density at ϩ90 mV (means Ϯ SE, n ϭ 6 -9) in DCs without (open bar, control) and with (closed bars) pretreatment with 100 nM rapamycin for the indicated time points (in hours). *P Ͻ 0.05, ***P Ͻ 0.001, significant difference from control (ANOVA). D: dose dependence of rapamycin effect on Kv current density at ϩ90 mV (means Ϯ SE, n ϭ 8 -14) in DCs without (open bar, control) and with 12-h pretreatment (closed bars) with rapamycin at indicated concentration (in nM). ***P Ͻ 0.001, significant difference from control (ANOVA).
investigated. All experiments were repeated with at least three batches of oocytes; in all repetitions, qualitatively similar data were obtained.
Statistical analysis. Data are provided as means Ϯ SE, and n represents the number of independent experiments. All data were tested for significance using Student's unpaired two-tailed t-test or ANOVA (Dunnett's test), where applicable, and only results with P Ͻ 0.05 were considered statistically significant.
RESULTS
Ion channel activity in mouse bone marrow-derived DCs was analyzed utilizing whole cell patch-clamp experiments. As shown in Fig. 1 , DCs express Kv channels. They presumably belong to Kv1.3 and Kv1.5 families (45, 56, 66) . Pretreatment of the cells with rapamycin was followed by a gradual decline of Kv channel activity, an effect becoming significant with 50 nM rapamycin and 6 h of incubation (Fig. 1, C and D) .
The rising phase of activating channel currents was analyzed by single exponential fitting. Activation time constants were not different between control and rapamycin-treated DCs ( Fig. 2A ). Fitting the current decay after activation at depolarizing potentials to a single exponential function demonstrated a significant difference at ϩ 70 mV (Fig. 2B) . Pretreatment with rapamycin resulted in a smaller inactivation time constant, suggesting that rapamycin causes faster Kv channel inactivation.
The inhibitory effect of rapamycin on Kv channel activity suggests that Kv1.3 and/or Kv1.5 channels are regulated by mTOR. To test this hypothesis directly, cRNA encoding Kv1.3 or Kv1.5 was injected into Xenopus oocytes without or with additional injection of cRNA encoding mTOR.
In Xenopus oocytes expressing Kv1.3, but not in waterinjected oocytes, Kv currents were observed with typical properties of Kv1.3 (Fig. 3 ). The Kv current was significantly increased by additional coexpression of mTOR (Fig. 3) . (Fig. 3, B  and C) .
In Xenopus oocytes expressing Kv1.5, the effect of mTOR on the voltage-gated current was similar as in Kv1.3-expressing oocytes (Fig. 4) . The Kv1.5 currents were again significantly increased by additional coexpression of mTOR (Fig. 4) , an effect abolished by rapamycin (Fig. 4, B and C) . In the absence of mTOR, preincubation with rapamycin (75 nM, 12 h) did not significantly modify the Kv1.5 current. The current at ϩ50 mV in Kv1.5-expressing oocytes was 901 Ϯ 81 pA (n ϭ 9) in the absence and 876 Ϯ 66 pA (n ϭ 8) in the presence of rapamycin.
Analysis of activation and inactivation time constants of Kv1.3 and Kv1.5 ( Fig. 5) revealed that mTOR affected activation and inactivation of Kv1.3, but not of Kv1.5. Coexpression with mTOR resulted in decreased activation and an increased inactivation of Kv1.3, suggesting that mTOR causes faster Kv1.3 channel activation and slower Kv1.3 channel inactivation. The stimulating effect of mTOR on Kv1.3 was abrogated by preincubation of the oocytes with rapamycin (Fig. 5) .
DISCUSSION
The present study confirms previous observations (45, 47, 56) that bone marrow-derived dendritic cells (DCs) express voltage-gated K ϩ (Kv) channels, which are rapidly activated upon cell membrane depolarization. More importantly, the observations disclose a novel regulator of those channels. As apparent from heterologous expression in Xenopus oocytes, the Kv1.3 and Kv1.5 channels are upregulated by the mammalian target of rapamycin. Accordingly, Kv channels in DCs are downregulated by rapamycin. Rapamycin concentrations within the human whole blood through therapeutic range are reported as 5-16 nM (42). Slightly higher concentrations used in the present study (50 -100 nM) aimed to fully block mTOR.
In Xenopus oocytes, mTOR alters Kv1.3 channel kinetics, accelerating Kv1.3 channel activation and slowing down Kv1.3 channel inactivation, the latter effect abrogated by rapamycin. In DCs the effect of rapamycin required at least 6 h, suggesting that rapamycin may be effective in part by modulating gene expression. However, there was no change in mRNA level of Kv1.3 and Kv1.5 when DCs were incubated with rapamycin (data not shown), pointing to an influence of rapamycin/mTOR on Kv channels in DCs by mechanisms other than regulation of transcription. In Chinese hamster ovary (CHO) cells stably expressing Kv1.3 channels, rapamycin inhibited those channels upon acute drug administration (1). However, the effect re- Fig. 2 . Rapamycin affects onset of inactivation, but not activation, of Kv currents in DCs. A: activation time constants ( activation) was determined by fitting single exponential functions to the rising phase of currents at voltages from ϩ10 to ϩ70 mV of control cells (n ϭ 8) and cells pretreated with rapamycin (100 nM, overnight, n ϭ 9). B: inactivation time constants ( inactivation) were determined by fitting single exponential functions to the decaying phase of currents at voltages from ϩ50 to ϩ90 mV of control cells (n ϭ 8) and cells pretreated with rapamycin (100 nM, overnight, n ϭ 9). **P Ͻ 0.01, statistical significance according to Student's t-test analysis. quired much higher concentrations (IC 50 of 6.7 M) than in our study. In Kv1.3-expressing CHO cells, rapamycin enhanced the rate of current decay, an effect that we also observed at ϩ70 mV in DCs. Another immunosuppressant (and another mTOR inhibitor), FK-506, similarly blocked Kv1.3 and Kv1.5 in stably transfected CHO cells, and FK-506 caused a time-, concentration-, and use-dependent inhibition of Kv1.3 channels (1). The effect of FK-506 (IC 50 ϭ 5.6 M) resulted from a direct interaction with the Kv1.3 channel rather than modifications of the signal transduction pathway, including mTOR, since the effect of FK-506 was observed in excised inside-out patch devoid of diffusible cytosolic molecules required for phosphorylation/dephosphorylation (1) .
Earlier dual-electrode voltage-clamp experiments in Xenopus oocytes revealed that Kv1.3 (25, 31, 65 ) and Kv1.5 (61) channels are upregulated by the serum and glucocorticoidinducible kinase (SGK) isoforms SGK1 and SGK3. Similarly, overexpression of SGK1, SGK2, or SGK3 in human embryonic kidney (HEK) cells was shown to upregulate Kv channels (24, 25, 65). The same channels were shown to be activated by treatment of the HEK cells (25) and fibroblasts (55) with IGF-I. Activation of SGK has previously been shown to involve mTOR (17, 26, 34, 67) . Thus, it is tempting to speculate that mTOR is effective through stimulation of the SGK isoforms, which in turn upregulate Kv1.3 and Kv1.5. Inhibition of the PI3K leads, however, to upregulation of Kv channel activity in DCs (56) , an effect in seeming contrast to the stimulating effect of SGK isoforms on Kv channels in other cells. Kv channels are further regulated by p38 kinase (53) , which is in turn known to upregulate SGK1 expression (39) .
Kv1.3 channels are regulated by a variety of further kinases, such as protein kinase A (12, 38) , protein kinase C (12), Src , overnight, bottom right) . The voltage protocol is shown (not to scale), whereby cells were held at Ϫ100 mV and voltage steps were applied in ϩ10-mV increments for 2,000 ms from Ϫ80 mV to ϩ50 mV. B: mean I-V relationships (Ϯ SE, n ϭ 9 -13) of peak Kv1.3 currents in Xenopus oocytes injected with water (छ), expressing Kv1.3 alone (), expressing Kv1.3 ϩ mTOR (), and expressing Kv1.3 ϩ mTOR, incubated with rapamycin (75 nM, overnight, OE). C: mean peak amplitude (Ϯ SE, n ϭ 9 -13) of Kv1.3 currents at ϩ50 mV in Xenopus oocytes injected with water (DEPC, light gray bar), expressing Kv1.3 (open bar), expressing Kv1.3 ϩ mTOR (closed bar), and expressing Kv1.3 ϩ mTOR, incubated with rapamycin (75 nM, overnight, dark gray bar). *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001, significant difference between indicated groups (ANOVA).
kinases (10, 14) , Lck56 (28, 58), neurotrophin B receptor kinase (13) , and EGF receptor tyrosine kinase (8) .
The K ϩ channels maintain the cell membrane potential, which in turn provides the electrical driving force for Ca 2ϩ entry (49) . Accordingly, Kv channel blockers margatoxin and charybdotoxin decreased capacitative calcium entry in HEK cells (59) . DCs respond to lipopolysaccharide stimulation with a fast increase of intracellular calcium concentration, which is accomplished by both, Ca 2ϩ release from intracellular stores and Ca 2ϩ influx through Ca 2ϩ release-activated channel (CRAC) (45) . The Ca 2ϩ influx through CRAC depends on the activity of Kv channels. Inhibition of either CRAC or Kv channels leads to profound changes in DC functions, including changes in maturation, phagocytosis, migration, and cytokine production (45) .
In conclusion, the serine/threonine kinase mTOR stimulates the voltage-gated K ϩ channels Kv1.3 and Kv1.5, an effect shaping the cell membrane potential and function of bone marrow-derived DCs. The voltage protocol is shown (not to scale), whereby cells were held at Ϫ100 mV and voltage steps were applied in ϩ10-mV increments for 2,000 ms from Ϫ80 mV to ϩ50 mV. B: mean I-V relationships (Ϯ SE, n ϭ 8 -10) of peak Kv1.5 currents in Xenopus oocytes injected with water (छ), expressing Kv1.5 alone (), expressing Kv1.5 ϩ mTOR (), and expressing Kv1.5 ϩ mTOR, incubated with rapamycin (75 nM, overnight, OE). C: mean peak amplitude (Ϯ SE, n ϭ 8 -10) of Kv1.5 currents at ϩ50 mV in Xenopus oocytes injected with water (DEPC, light gray bar), expressing Kv1.5 (open bar), expressing Kv1.5 ϩ mTOR (closed bar), and expressing Kv1.5 ϩ mTOR, incubated with rapamycin (75 nM, overnight, dark gray bar). *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001, significant difference between indicated groups (ANOVA). . mTOR affects onset of activation and inactivation of Kv1.3 but not Kv1.5. A and C: activation time constants were determined by fitting single exponential functions to the rising phase of currents at voltages from ϩ20 to ϩ60 mV of Kv1.3, Kv1.3 ϩ mTOR, and Kv1.3 ϩ mTOR ϩ rapamycin (75 nM, overnight, n ϭ 8 -9) (A) or Kv1.5, Kv1.5 ϩ mTOR, and Kv1.5 ϩ mTOR ϩ rapamycin (75 nM, overnight; n ϭ 8 -10) (C). *P Ͻ 0.05, statistical significance between Kv1.3 and Kv1.3 ϩ mTOR (ANOVA). B and D: inactivation time constants were determined by fitting single exponential functions to the decaying phase of currents at voltages from ϩ30 to ϩ60 mV of Kv1.3, Kv1.3 ϩ mTOR, and Kv1.3 ϩ mTOR ϩ rapamycin (75 nM, overnight, n ϭ 14 -19) (B) or Kv1.5, Kv1.5 ϩ mTOR, and Kv1.5 ϩ mTOR ϩ rapamycin (75 nM, overnight, n ϭ 7-28) (D). *P Ͻ 0.05, ***P Ͻ 0.001, statistical significance between Kv1.3 and Kv1.3 ϩ mTOR and between Kv1.3 ϩ mTOR and Kv1.3 ϩ mTOR ϩ rapamycin (ANOVA).
